<DOC>
	<DOCNO>NCT01604785</DOCNO>
	<brief_summary>There little advancement abortive migraine therapy recent decade , proven treatment exist acute migraine , particularly child . Propofol , general anesthetic , suggest effective treatment migraine headache adult use subanesthetic dos ( low dos use anesthesia sedation ) . Initial retrospective review investigator experience propofol migraine child suggest safe may effective standard treatment use emergency department . The investigator retrospective series small subject population large study need compare propofol current available treatment . All subject present pediatric emergency department signs/symptoms migraine headache screen study . Subjects eligible provide information study consent/assent form member research team , ask whether interested participate . All study subject receive acetaminophen ( Tylenol ) ibuprofen ( Motrin ) headache already try first-line treatment home ; persistent symptom require treatment consent participate study randomize receive either standard treatment propofol . Standard treatment currently consist `` cocktail '' medication include anti-nausea medicine ( metoclopramide diphenhydramine ) analgesic ( ketorolac ) well intravenous fluid . Subjects assign experimental group ( Propofol ) receive intravenous fluid five dos propofol . All subject undergo assessment pain ( self-rated scale 0-10 ) treatment . During treatment close monitoring vital sign . No additional laboratory test procedure involve . Post-visit clinical data collect subject 's medical record subject call telephone 24-48 hour discharge emergency department ask whether required additional treatment home medication medical professional OHSU . The study data present summary table outline subject ' clinical presentation prior treatment , response study drug visit . The main variable interest include effectiveness ( determine reduction self-reported pain score ) , length stay pediatric emergency department , recurrent headache require emergency treatment within 24 hour whether adverse effect occur . These compare 2 study group basic statistic .</brief_summary>
	<brief_title>Low-dose Propofol Pediatric Migraine</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Dopamine Antagonists</mesh_term>
	<criteria>Children 718 year age Acute Migraine Headache Head Trauma CNS infection CNS tumor Previous CNS surgery device</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Migraine Headache</keyword>
	<keyword>Pediatric</keyword>
</DOC>